KHKarl Georg Haeusler

Karl Georg Haeusler

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karl Georg Haeusler has a total of 891 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Artificial intelligence in an ageing population

    by Stephen Lim, Marguerite O’RIordan, Bryony Dennison, Ibrahim Zaidi, Maximilian U. Friedrich, Oliver Todd, David Wong, Karl Georg Haeusler, Atul Anand, Alishba Rizvi, et al.

    Artificial intelligence is increasingly being applied to the assessment, monitoring and care of older adults, with potential benefits across both population health and individual clinical practice. This narrative review examines current and emerging applications of AI in common conditions and care needs associated with ageing, including hypertension, stroke, myocardial infarction, Parkinson’s disease, osteoporosis, sarcopenia and supportive care robotics. Across these domains, AI-enabled analysis of electronic health records, electrocardiograms, imaging, video, wearable-sensor data and home-monitoring measurements may support earlier disease detection, more objective functional assessment, personalised risk prediction and treatment, and greater independence. Computer-vision approaches may provide detailed measures of movement following stroke and in Parkinson’s disease, while opportunistic analysis of existing imaging may improve recognition of low bone mineral density, vertebral fractures and reduced muscle health. Care robots may additionally assist with companionship, medication management and falls detection. However, much of the evidence remains based on selected datasets, proof-of-concept studies or controlled settings. Algorithmic bias, limited representation of frail and multimorbid older adults, privacy, governance, interpretability, interoperability, user burden and workforce consequences remain important barriers. AI should therefore complement rather than replace clinical judgement. Equitable implementation will require representative datasets, rigorous external and prospective validation, transparent models, user-centred design and evaluation of clinically meaningful outcomes.

  • Open Access

    Neuroimaging signatures of facial onset sensory and motor neuronopathy (FOSMN)

    by Angela Rosenbohm, Francisco Herrera-Angeles, Hans-Jürgen Huppertz, Karl Georg Haeusler, Jochen H. Weishaupt, Hans-Peter Müller, Jan Kassubek

    Facial onset sensory and motor neuronopathy (FOSMN) is an exceptionally rare condition characterized by progressive facial paresthesia and the subsequent appearance of bulbar symptoms with rostro-caudal motor and sensory deficits sometimes extending to the hand muscles. The pathophysiological understanding of this disorder is very limited. In order to identify patterns of neuroanatomical involvement within the brain, we applied advanced magnetic resonance imaging-based techniques to a group of six patients with the diagnosis of FOSMN, using unbiased analysis techniques with atlas-based volumetry of volume-rendering T1-weighted data and whole brain-based spatial statistics of diffusion tensor imaging (DTI). The volumetric data showed significant global atrophy with prominent involvement of the medulla oblongata, while DTI demonstrated significant decreases in the right-hemispheric frontal lobe and bilaterally along the superior and inferior longitudinal fasciculi. In summary, this application of volumetry and DTI to a group of FOSMN patients demonstrated, beyond global brain atrophy as a correlate of a systemic disease process, regional atrophy in the brainstem/medulla oblongata, together with tract alterations of polymodal frontotemporoparietal interconnections. Future neuroimaging studies in larger patient groups of FOSMN are needed for detailed phenotype–neuroimaging correlations.

  • Open Access

    Yield of Atrial Fibrillation Screening according to Methodology and Patient Characteristics: An Individual Participant Data Meta-Analysis of 34,165 Individuals Screened for Atrial Fibrillation within the AFFECT-EU/AF-SCREEN Collaboration

    by Lucas Y Xing, William F McIntyre, Johan Engdahl, Matthias Daniel Zink, Nikolaus Albert Helmut Marx, Emma Svennberg, Katrin Kemp Gudmundsdottir, Jelle C L Himmelreich, Giuseppe Boriani, Davide Antonio Mei, et al.

    Backgrounds and Aims: Atrial fibrillation (AF) screening may reduce adverse outcomes through early initiation of preventive treatment. However, more data are warranted to inform the yield of different screening strategies. This study aimed to evaluate how patient characteristics and screening methodologies influence screening yield. Methods: We conducted an individual participant data meta-analysis of 12 European and North American study cohorts, by using generalized linear mixed models with random intercept at study level. Results: In this meta-analysis of 34,165 participants screened for AF (age 73.4 ± 7.5 years and 53.5% female), the screening yield increased with more intensive approaches, ranging from 0.83% [95% confidence interval (CI): 0.24-2.87] in single-timepoint screening, to 5.06% [95% CI: 3.55-7.17] in intermittent (i.e. repeated single-timepoint) screening, 4.81% [95% CI: 3.79-6.08] in short-term continuous monitoring (≤30 days), and up to 30.39% [95% CI: 28.06-32.84] in long-term continuous monitoring (>30 days). Advanced age, male sex, hypertension, and heart failure (HF) were associated with detection. Significant interactions were observed between screening approach and age, sex, HF, CHADS2, and NT-proBNP. These risk factors had a stronger influence on AF detection with single-timepoint screening, compared with more intensive methods. Conclusions: In this meta-analysis, AF screening yield varied substantially by patient characteristics and screening approach. Advanced age, male sex, and HF were independently associated with greater AF detection, particularly in those having single-timepoint screening. Our findings support tailoring the screening approach to the individual target population in clinical practice. Further studies to assess clinical outcomes following screening are needed and underway.

  • Open Access

    Association of oral anticoagulation persistence and health-related quality of life in stroke survivors with atrial fibrillation: long-term results of the Berlin atrial fibrillation registry

    by Lena Steindorf-Sabath, Manuel C. Olma, Serdar Tütüncü, Claudia Kunze, Ulrike Grittner, Jil Heege, Joanna Dietzel, Johannes Schurig, Peter U. Heuschmann, Matthias Endres, et al.

    Background: Persistence to oral anticoagulation (OAC) is crucial to prevent recurrent stroke in patients with atrial fibrillation (AF). Little is known about the association of OAC intake, persistence to OAC, and type of OAC with health-related quality of life (HRQoL) in stroke survivors with AF. Methods: This retrospective analysis of the multicenter Berlin Atrial Fibrillation Registry included 1,042 patients with acute ischemic stroke or transient ischemic attack (TIA) and AF. HRQoL data were measured at 3,12,24 and 36 months after stroke/TIA using the EQ-5D-3 L questionnaire (including EQ-Index and EQ-VAS). Associations between OAC status, persistence to and type of OAC (direct oral anticoagulants (DOACs) against vitamin K antagonists (VKAs)) at 12 and up to 36 months with HRQoL were examined using multivariable linear models. Results: Overall, 842 patients completed the 12-months follow-up and 437 patients the 36-months follow-up. After 12 months, OAC intake was associated with higher EQ-VAS scores (β = 6.70, p = 0.017), although this effect was not observed up to 36 months (ß= -3.67, p = 0.075). Non-persistence to OAC was associated with lower EQ-VAS scores at 12 (ß= -6.25, p = 0.004) and 36 months (ß= -5.39, p < 0.001). No evidenve of a statistically significant difference in HRQoL was found between patients persistent to DOACs and those persistent to VKAs. EQ-Index values were not statistically significantly affected. Conclusion: Non-persistence to OAC was associated with reduced EQ-VAS up to 36 months after stroke. Notably, no evidence of a statistically significant difference regarding HRQOL was found between patients persistent on DOAC or VKA. Ensuring long-term persistence to OAC may support HRQoL in stroke survivors with AF.

  • Systemic CXCL4 Levels and Clinical Outcomes in Acute Ischemic Stroke

    by Vivian Vogt, Christoph Vollmuth, Guido Stoll, Peter U. Heuschmann, Alexander M. Kollikowski, Mirko Pham, Karl Georg Haeusler, Hermann Neugebauer, Michael K. Schuhmann

    Introduction: Platelet activation within the intravascular ischemic compartment, as indicated by elevated CXCL4 levels, has been implicated in the pathogenesis of acute ischemic stroke (AIS). Based on this, the prognostic value of venous CXCL4 concentrations measured within 24 hours of stroke onset was investigated. Methods: A total of 111 patients with moderate to severe AIS (NIHSS score ≥6 and/or an indication for mechanical recanalization) were enrolled in this prospective, single-center study. Plasma CXCL4 levels were measured using ELISA. Functional outcome was assessed by telephone interview at 3 months (±14 days) using the modified Rankin Scale (mRS); poor outcome was defined as an mRS score ≥3. Multiple logistic regression analysis was adjusted for age, ASPECTS, baseline NIHSS score, NIHSS score at 24 h, and recanalization therapy. Results: CXCL4 levels did not differ significantly between patients with poor and good outcomes [118.8 ng/ml vs. 119.5 ng/ml, p = 0.60], nor between non-survivors and survivors [127.2 ng/ml vs. 117.6 ng/ml, p = 0.85]. CXCL4 was not independently associated with poor outcome [aOR: 0.33; 95% CI: 0.04-2.06]. Discussion: CXCL4 is abundantly released following platelet activation and has therefore emerged as a promising biomarker candidate. However, systemic CXCL4 levels were not associated with functional outcome in AIS. Conclusion: These findings suggest that early venous CXCL4 levels are not a suitable biomarker for predicting functional outcome after AIS.

  • Open Access

    Integrating Metabolic, Perfusion, and Microstructural Parameters for Quantitative Neuroimaging in Rare Neurodegenerative Diseases: A Hybrid PET/MRI Approach

    by Joachim Strobel, Hans-Peter Müller, Laura Michelberger, Anastasia Nosanova, Wolfgang Thaiss, Karl Georg Haeusler, Jochen H. Weishaupt, Kornelia Kreiser, Ambros J. Beer, Meinrad Beer, et al.

    B ackground/Objectives: The use of quantitative neuroimaging to establish objective biomarkers in neurodegenerative diseases (NDD) has attracted increasing interest over the last decade. Advanced magnetic resonance imaging (MRI) such as arterial spin labeling (ASL) and diffusion tensor imaging (DTI), as well as [18F]fluorodeoxyglucose ([18F]FDG) positron emission tomography (PET), could provide clinically meaningful biomarkers and may support differential diagnosis. The aim of this investigator-initiated, single-center, retrospective comparative study was to implement a framework for multimodal neuroimaging to evaluate cases with rare NDD, using a methodological approach that integrates metabolic, perfusion, and microstructural parameters from simultaneous FDG-PET/MRI, and to investigate its potential to facilitate diagnosis. Methods: Three patients with pathological motor signs (1f/2m; 63, 73, and 52 years) and 19 control subjects with subjective cognitive deficits (SCDs) underwent combined FDG-PET/MRI with pseudo-continuous ASL and DTI. Standardized uptake values (SUVs), relative cerebral blood flow (rCBF), and fractional anisotropy (FA) were calculated to identify pattern alterations in individual patients based on parameterization mapping. The final diagnosis was corticobasal degeneration (CBD, n = 1) or primary lateral sclerosis (PLS, n = 2). Results: At the individual patient level, disease-specific changes in defined brain regions could be demonstrated and quantified compared to control subjects. All three patients showed significantly decreased FA, primarily along parts of the course of the corticospinal tract (CST). In the patient with CBD, asymmetric SUVR and rCBF decreases were observed, mostly overlapping with motor regions. In the two patients with PLS, SUVR revealed mostly unspecific findings (hypothetically due to a slow progression rate or due to potentially early disease stages), while ASL indicated decreased rCBF primarily overlapping within the motor cortex. Changes at the gray matter level were primarily located adjacent to changes in white matter, as indicated by the multimodal analysis approach using simultaneously acquired FDG-PET/MRI data. Conclusions: According to this proof-of-concept study, multimodal neuroimaging by the combination of quantitative MRI and FDG-PET has the potential to guide differential diagnosis in rare NDDs, especially if clinical diagnosis is not straightforward to achieve. Since particularly early diagnosis remains essential for patient counseling, effective treatment, and clinical management, the present framework appears helpful to be developed further until it aligns and integrates with clinical routine.


  • Cardiac monitoring for detection of atrial fibrillation after TIA: An updated systematic review and meta-analysis

    by Alexander W Veltkamp, Eleni Korompoki, Lucio D’ANna, Manuel C Olma, Karl Georg Haeusler, Matthias Endres, Roland Veltkamp

    Background and aims: The optimal monitoring strategy for atrial fibrillation (AF) detection after transient ischemic attacks (TIAs) is uncertain, as existing evidence is largely derived from ischemic stroke or mixed stroke-TIA populations. This systematic review and meta-analysis aimed to determine the rate of newly diagnosed AF in TIA patients using different electrocardiographic monitoring modalities and durations. Methods: A literature search from 1966 through 31 May 2025 was conducted according to Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines using a protocol registered on PROSPERO (CRD420251075716). Prospective observational studies and randomized controlled trials including TIA patients who underwent at least 12 h of cardiac monitoring were eligible. The primary outcome was newly detected AF lasting at least 30 s, with subgroup analyses by monitoring duration and modality. Results: Forty-two studies enrolling 3981 TIA patients were included. The pooled AF detection rate was 6.5% (95% confidence interval (CI): 4.5–9.3). AF detection rates increased with monitoring duration: 3.5% at 1 day, 6.3% at 7 days, 9.6% at 30 days, 13.1% at 90 days, and 19.1% at 12 months, respectively. Implantable cardiac monitors yielded statistically significantly higher AF detection rates than non-invasive cardiac monitoring (20.8% vs. 4.7%, p < 0.0001). AF detection appeared higher in selected cohorts (based on older age, undetermined cause, and more extensive cardiovascular work-up) than in unselected cohorts (9.0% vs. 4.5%, p = 0.031). However, stratified analysis of non-invasive monitoring showed no difference between selected and unselected TIA patients (5.0% (95% CI: 2.3–10.5) vs. 4.5% (95% CI: 3.1–6.5)). Substantial heterogeneity was observed among studies ( I ² = 81.9%). Conclusion: This meta-analysis found high rates of newly detected AF in TIA patients undergoing prolonged cardiac monitoring, which are similar to rates previously reported after ischemic stroke. Studies using implantable cardiac monitors specifically in TIA patients are scarce. Randomized trials are needed for a face-to-face comparison of different monitoring strategies and to determine whether prolonged cardiac monitoring improves clinical outcomes in TIA patients.


  • Open Access

    Prevention in stroke - Current state, present gaps and probable next steps

    by Christian S. Thielscher, Felipe A. Montellano, Dorothee Saur, Agnes Flöel, Gabor C. Petzold, Karl Georg Haeusler

    Background: Stroke is a leading cause of death and disability, and the top contributor to neurological disability-adjusted life years globally. Current trends suggest that stroke incidence will continue to rise, especially in low- and middle-income countries. Main body: Prevention opportunities are substantial because the majority of stroke burden is linked to modifiable risk factors. Thus, stroke incidence can effectively be reduced if proven interventions are implemented early, consistently, and at sufficient scale. Effective prevention requires both individualized, risk-based targets and interventions, and health-system approaches that support systematic detection, longitudinal control, and sustained adherence in routine care. Importantly, prevention benefits will be maximized only if access is equitable and if prevention goals can be achieved across the population at large, including so far underserved groups that combine multiple cardiovascular risk factors and low affinity to traditional health care prevention programs. Future directions: Next steps may include strengthening of primary-care-based prevention programs, routine surveillance of risk-factor control, outreach to underserved groups, and transparent quality indicators. Long-term follow-up is essential to sustain risk-factor control and to enable translation of evidence into population-level impact.


  • Schlaganfallrisiko im Zuge einer linksatrialen Katheterablation bei Vorhofflimmern

    by Karl Georg Häusler, Karl Georg

    Zusammenfassung Der periprozedurale Schlaganfall gehört zu den relevantesten Komplikationen einer linksatrialen Katheterablation bei Vorhofflimmern. Sowohl prozedur- und patientenspezifische Faktoren als auch die Erfahrung der Interventionalisten bzw. des intervenierenden Zentrums sind für das periprozedurale Schlaganfallrisiko relevant. In den letzten Jahren konnte das periprozedurale Schlaganfallrisiko in spezialisierten Zentren auf unter 0,5 % gesenkt werden, wozu auch technische Fortschritte und die interdisziplinäre Durchführung von MRT-basierten Studien zum prozedurassoziierten zerebralen Embolierisiko beigetragen haben. Für die Behandlung peri- und postprozeduraler Schlaganfälle sind neben einer entsprechenden Sensibilisierung insbesondere klar definierte Standardarbeitsanweisungen (SOP) von Bedeutung. Diese sollten sowohl präventive Strategien zur Vermeidung eines Schlaganfalls, das periprozedurale Blutdruckmanagement, die peri- und postprozedurale Gerinnungshemmung als auch deren Antagonisierung im Falle einer (intrakraniellen) Blutung umfassen, sowie die weiteren innerklinischen Behandlungspfade skizzieren. Im Falle einer akuten zerebralen Ischämie sollte innerhalb von 4,5 h nach Symptombeginn bei einem klinisch als relevant angesehenen neurologischen Defizit im interdisziplinären Dialog die Möglichkeit einer systemischen Thrombolyse geprüft werden, basierend auf einer individuellen Nutzen-Risiko-Abwägung unter Berücksichtigung der Leitlinienempfehlungen und der produktspezifischen Fachinformation. Bei Bestehen eines akuten proximalen Verschlusses der hirnversorgenden Arterien und entsprechendem klinischen Bild ist in einem Zeitfenster von bis zu 24 h nach (möglichem) Symptombeginn die Indikation für eine katheterbasierte („mechanische“) Rekanalisation zu evaluieren, da diese unabhängig von der gerinnungshemmenden Medikation erfolgen kann, auch wenn bislang keine randomisierten Studien zur Wirksamkeit und Sicherheit dieser auf eine Rekanalisation abzielenden Therapien bei periprozeduralem Schlaganfällen vorliegen. Gemäß einer selektiven Literaturrecherche sowie eigener Vorarbeiten sollen in diesem Übersichtsartikel Empfehlungen zur Vermeidung und Akuttherapie periprozeduraler Schlaganfälle gegeben werden.

  • Open Access

    Time-critical quality assessment of a digital hub for acute stroke care: Implementing key performance indicators within the CAEHR (CArdiovascular diseases – Enhancing Healthcare through cross-sectoral Routine data integration) project

    by Anna-Lena Hofmann, Julia Wendel, Udo Selig, Peter Cidlinsky, Christine Vogl, Sabrina Scriba, Christian Zech, Thomas Wurmb, Maximilian Ertl, Muntazir Mehdi, et al.